Clinical Neurology, Udine University Hospital, Piazza Santa Maria della Misericordia, 15, 33100 Udine, Italy.
Department of Medicine (DAME), University of Udine, 33100 Udine, Italy.
Int J Mol Sci. 2023 Jun 25;24(13):10615. doi: 10.3390/ijms241310615.
In the context of neurodegenerative disorders, cognitive decline is frequently reported in older population. Recently, numerous metabolic pathways have been implicated in neurodegeneration, including signaling disruption of insulin and other glucose-regulating hormones. In fact, Alzheimer's disease has now been considered as "type-3 diabetes". In this review, we tried to clarify the role of sleep impairment as the third major player in the complex relationship between metabolic and neurodegenerative diseases. Altered sleep may trigger or perpetuate these vicious mechanisms, leading to the development of both dementia and type 2 diabetes mellitus. Finally, we analyzed these reciprocal interactions considering the emerging role of the gut microbiota in modulating the same processes. Conditions of dysbiosis have been linked to circadian rhythm disruption, metabolic alterations, and release of neurotoxic products, all contributing to neurodegeneration. In a future prospective, gut microbiota could provide a major contribution in explaining the tangled relationship between sleep disorders, dementia and diabetes.
在神经退行性疾病的背景下,老年人经常报告认知能力下降。最近,许多代谢途径已被牵涉到神经退行性变中,包括胰岛素和其他血糖调节激素的信号转导中断。事实上,阿尔茨海默病现在被认为是“第三型糖尿病”。在这篇综述中,我们试图阐明睡眠障碍作为代谢和神经退行性疾病之间复杂关系中的第三个主要因素的作用。睡眠改变可能引发或延续这些有害机制,导致痴呆和 2 型糖尿病的发展。最后,我们分析了这些相互作用,考虑了肠道微生物群在调节这些相同过程中的新兴作用。肠道菌群失调与昼夜节律紊乱、代谢改变和神经毒性产物的释放有关,所有这些都导致神经退行性变。在未来的展望中,肠道微生物群可能会对解释睡眠障碍、痴呆和糖尿病之间复杂关系做出重大贡献。